Barclays’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93K Sell
11,202
-143,690
-93% -$1.49M ﹤0.01% 4052
2025
Q4
$1.91M Sell
154,892
-25,258
-14% -$271K ﹤0.01% 2965
2025
Q3
$1.59M Sell
180,150
-523
-0.3% -$4.07K ﹤0.01% 3046
2025
Q2
$1.15M Buy
180,673
+68,362
+61% +$391K ﹤0.01% 3239
2025
Q1
$546K Buy
112,311
+17,788
+19% +$147K ﹤0.01% 3475
2024
Q4
$904K Buy
94,523
+55,215
+140% +$507K ﹤0.01% 3441
2024
Q3
$328K Buy
39,308
+30,792
+362% +$280K ﹤0.01% 4034
2024
Q2
$58.1K Sell
8,516
-29,688
-78% -$128K ﹤0.01% 4146
2024
Q1
$96.7K Sell
38,204
-101,391
-73% -$229K ﹤0.01% 4447
2023
Q4
$335K Buy
139,595
+26,191
+23% +$61.5K ﹤0.01% 4138
2023
Q3
$386K Sell
113,404
-170,003
-60% -$942K ﹤0.01% 2945
2023
Q2
$2.08M Buy
283,407
+126,386
+80% +$1.17M ﹤0.01% 1861
2023
Q1
$1.63M Sell
157,021
-81,394
-34% -$984K ﹤0.01% 2337
2022
Q4
$2.82M Buy
238,415
+68,225
+40% +$1.06M ﹤0.01% 2014
2022
Q3
$3.57M Buy
170,190
+146,857
+629% +$4.09M ﹤0.01% 1369
2022
Q2
$724K Sell
23,333
-41,222
-64% -$1.41M ﹤0.01% 2593
2022
Q1
$2.65M Buy
64,555
+684
+1% +$30.2K ﹤0.01% 1655
2021
Q4
$2.78M Buy
63,871
+17,026
+36% +$770K ﹤0.01% 2157
2021
Q3
$2.35M Buy
46,845
+2,817
+6% +$171K ﹤0.01% 2210
2021
Q2
$2.77M Sell
44,028
-8,725
-17% -$561K ﹤0.01% 1974
2021
Q1
$4.9M Buy
52,753
+11,576
+28% +$1.19M ﹤0.01% 1535
2020
Q4
$3.69M Sell
41,177
-26,485
-39% -$2.43M ﹤0.01% 1741
2020
Q3
$6.99M Sell
67,662
-3,857
-5% -$416K 0.01% 1199
2020
Q2
$5.66M Sell
71,519
-56,272
-44% -$4.19M 0.01% 1288
2020
Q1
$7.39M Sell
127,791
-57,468
-31% -$3.31M 0.01% 1190
2019
Q4
$9.99M Buy
185,259
+128,299
+225% +$6.96M 0.01% 1399
2019
Q3
$2.98M Sell
56,960
-6,338
-10% -$295K ﹤0.01% 2393
2019
Q2
$3.06M Buy
63,298
+23,201
+58% +$1.11M ﹤0.01% 2407
2019
Q1
$2.02M Buy
40,097
+13,474
+51% +$795K ﹤0.01% 2562
2018
Q4
$1.58M Sell
26,623
-19,959
-43% -$1.29M ﹤0.01% 2646
2018
Q3
$3.07M Buy
46,582
+32,973
+242% +$1.92M ﹤0.01% 2378
2018
Q2
$687K Sell
13,609
-11,468
-46% -$598K ﹤0.01% 3641
2018
Q1
$1.32M Buy
25,077
+2,621
+12% +$131K ﹤0.01% 2890
2017
Q4
$1.04M Buy
22,456
+8,900
+66% +$375K ﹤0.01% 3079
2017
Q3
$548K Sell
13,556
-7,169
-35% -$259K ﹤0.01% 3532
2017
Q2
$702K Buy
20,725
+19,465
+1,545% +$601K ﹤0.01% 3197
2017
Q1
$37K Sell
1,260
-3,676
-74% -$112K ﹤0.01% 5496
2016
Q4
$162K Buy
4,936
+1,749
+55% +$52.4K ﹤0.01% 4386
2016
Q3
$101K Buy
3,187
+1,140
+56% +$33.1K ﹤0.01% 4509
2016
Q2
$58K Sell
2,047
-18,751
-90% -$735K ﹤0.01% 4751
2016
Q1
$749K Buy
20,798
+20,642
+13,232% +$729K ﹤0.01% 2772
2015
Q4
$7K Sell
156
-2,958
-95% -$103K ﹤0.01% 5483
2015
Q3
$87K Sell
3,114
-9,193
-75% -$303K ﹤0.01% 4700
2015
Q2
$393K Buy
12,307
+11,226
+1,038% +$348K ﹤0.01% 3669
2015
Q1
$30K Sell
1,081
-982
-48% -$28.2K ﹤0.01% 5613
2014
Q4
$56K Buy
2,063
+1,035
+101% +$24.7K ﹤0.01% 5625
2014
Q3
$21K Sell
1,028
-36,568
-97% -$837K ﹤0.01% 6447
2014
Q2
$827K Sell
37,596
-41,800
-53% -$974K ﹤0.01% 3509
2014
Q1
$1.99M Buy
79,396
+75,249
+1,815% +$1.9M ﹤0.01% 2555
2013
Q4
$90K Sell
4,147
-13,649
-77% -$285K ﹤0.01% 5724
2013
Q3
$338K Sell
17,796
-2,080
-10% -$37.1K ﹤0.01% 4523
2013
Q2
$287K Buy
+19,876
New +$288K ﹤0.01% 4826

Other funds holding EBS